Advances and applications of biosensors in pulmonary hypertension

被引：0
作者：
Zhi Liu [1 ]
Zhuojun Bai [2 ]
Xiang Chen [3 ]
Yajie Chen [3 ]
Zhu Chen [1 ]
Li Wang [1 ]
Yi He [3 ]
Yuan Guo [2 ]
机构：
[1] Graduate Collaborative Training Base of Zhuzhou Central Hospital, Hengyang Medical School, University of South China, Hunan, Hengyang
[2] Department of Cardiovascular Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, No. 116 South Changjiang Road, Hunan, Zhuzhou
[3] Department of Laboratory, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, No. 116 South Changjiang Road, Hunan, Zhuzhou
来源：
Respiratory Research | / 26卷 / 1期
关键词：
Biomarkers; Biosensors; Nanomaterials; Pulmonary hypertension;
D O I：
10.1186/s12931-025-03221-w
中图分类号：
学科分类号：
摘要：
Pulmonary hypertension (PH) is a serious disease characterized by elevated pulmonary artery pressure, with its prevalence and incidence continuously increasing, posing a threat to the lives of many patients worldwide. Due to the complex etiology of PH and the lack of specificity in clinical manifestations, there is currently a lack of effective and specific methods for early diagnosis in clinical practice. Biosensors hold significant promise for the early detection, therapeutic monitoring, prognostic evaluation, and personalized treatment of PH, owing to their rapid, sensitive, and highly selective characteristics. The rapid development of various types of biosensors, such as electrochemical biosensors, optical biosensors, microfluidic biosensors, and wireless biosensors, combined with the use of nanomaterials, makes the rapid and accurate detection of PH-related biomarkers possible. Despite the broad application prospects of biosensors in the field of PH, challenges remain in terms of sensitivity, selectivity, stability, and regulation. This article reviews the main pathophysiological mechanisms and commonly used biomarkers of PH, the types and principles of biosensors, and summarizes the progress of biosensors in PH research as well as the current challenges, in order to promote further in-depth research and the development of biosensor technology, thereby improving the diagnosis and treatment effects of PH. Clinical trial number: Not applicable. © The Author(s) 2025.
引用
收藏
相关论文
共 133 条
  • [51] Parikh R.V., Ma Y., Scherzer R., Heringer A.S., Macgregor J.S., Martin J.N., Et al., Endothelin-1 predicts hemodynamically assessed pulmonary arterial hypertension in HIV infection, PLoS ONE, 11, 1, (2016)
  • [52] Shafran I., Probst V., Panzenbock A., Sadushi-Kolici R., Gerges C., Wolzt M., Et al., Asymmetric dimethylarginine and NT-proBNP levels provide synergistic information in pulmonary arterial hypertension, JACC Heart Fail, 12, 6, pp. 1089-1097, (2024)
  • [53] Ergun K., Balbay Y., Cihan G., Aras D., Cagli K., Ayaz S., Et al., [Thrombotic, fibrinolytic and proliferative activities of pulmonary vascular bed in secondary pulmonary hypertension], Anadolu Kardiyol Derg, 5, 2, pp. 95-100, (2005)
  • [54] Duan A., Huang Z., Zhao Z., Zhao Q., Jin Q., Yan L., Et al., The potential of Cystatin C as a predictive biomarker in pulmonary hypertension, BMC Pulm Med, 23, 1, (2023)
  • [55] Wauthier L., Favresse J., Hardy M., Douxfils J., Le Gal G., Roy P.M., Et al., D-Dimer Testing in Pulmonary Embolism with A Focus on Potential Pitfalls: A Narrative Review, (2022)
  • [56] Torbicki A., Kurzyna M., Kuca P., Fijalkowska A., Sikora J., Florczyk M., Et al., Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension, Circulation, 108, 7, pp. 844-848, (2003)
  • [57] Andryukov B.G., Lyapun I.N., Matosova E.V., Somova L.M., Biosensor technologies in medicine: from detection of biochemical markers to research into molecular targets (Review), Sovrem Tekhnologii Med, 12, 6, pp. 70-83, (2021)
  • [58] Zhang H., Applications of advanced nanomaterials in sensor devices, Mater (Basel), 24, (2022)
  • [59] Udoh E.E., Hermel M., Bharmal M.I., Nayak A., Patel S., Butlin M., Et al., Nanosensor technologies and the digital transformation of healthcare, Per Med, 20, 3, pp. 251-269, (2023)
  • [60] Bhalla N., Jolly P., Formisano N., Estrela P., Introduction to biosensors, Essays Biochem, 60, 1, pp. 1-8, (2016)
12345678910